News
FDA issued Complete Response Letter Capricor plans to resubmit its BLA to include data from the ongoing Phase 3 HOPE-3 trial ...
The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...
The FDA has issued more than 200 complete response letters, which detail reasons for non-approval of drug applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results